Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Erdosteine effect on systemic inflammation biomarkers during COPD exacerbations
2008-008529-32Phase 3Active
- Sponsor
- Azienda USL 1 di Massa e Carrara
- Start
- Jan 2009
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3 trial of erdosteine in chronic obstructive pulmonary disease (COPD), sponsored by Azienda USL 1 di Massa e Carrara. Started Jan 2009; status: active.
02
Drugs
erdosteine
03
Conditions
chronic obstructive pulmonary disease (COPD)
Beyond the preview
Go deeper on 2008-008529-32.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2008-008529-32.